{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T14:24:31Z","timestamp":1777991071264,"version":"3.51.4"},"reference-count":27,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate the clinical and health status outcomes of patients undergoing superficial femoral artery (SFA) revascularization using the <jats:italic>Shape Memory Alloy Recoverable Technology<\/jats:italic> (S.M.A.R.T.\u00ae) nitinol self\u2010expanding stent through 3 years of follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Background<\/jats:title><jats:p>Limited long\u2010term data are available describing the durability of benefits after femoropopliteal revascularization.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a multicenter, prospective, core\u2010lab adjudicated study, 250 subjects with de novo or restenotic femoropopliteal arterial lesions were treated with the S.M.A.R.T.\u00ae stent. The primary endpoint of target vessel patency, a composite of ultrasound\u2010assessed patency and freedom from clinically driven target lesion revascularization (TLR), was evaluated through 3 years. Secondary endpoints included stent fracture and health status. Health status was measured using generic and disease\u2010specific instruments, including the Peripheral Artery Questionnaire (PAQ).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>At 3\u2010year follow\u2010up, Kaplan\u2010Meier estimated target vessel patency was 72.7%, freedom from clinically driven TLR was 78.5%, and the incidence of stent fracture was 3.6%. The PAQ summary score was markedly impaired at baseline (mean 37.3\u2009\u00b1\u200919.6 points) and improved substantially at 1 month (mean change from baseline of 31.4 points, 95% CI: 28.5\u201034.3; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). Disease\u2010specific health status benefits assessed by the PAQ were largely preserved through 3 years of follow\u2010up (mean change from baseline, 28.0 points, 95% CI: 24.3\u201031.7; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In patients undergoing revascularization for moderately complex SFA disease, use of the self\u2010expanding S.M.A.R.T\u00ae stent was associated with a high rate of target vessel patency through 3 years and led to substantial and sustained health status benefits.<\/jats:p><\/jats:sec>","DOI":"10.1002\/ccd.27569","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T06:29:00Z","timestamp":1520576940000},"page":"106-114","source":"Crossref","is-referenced-by-count":14,"title":["Long\u2010term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3\u2010year results from the STROLL study"],"prefix":"10.1002","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8768-1376","authenticated-orcid":false,"given":"Matthew C.","family":"Bunte","sequence":"first","affiliation":[{"name":"St Luke's Hospital and University of Missouri\u2010Kansas City School of Medicine Saint Luke's Mid America Heart Institute Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cohen","sequence":"additional","affiliation":[{"name":"CardioVascular Institute, Division of Interventional Cardiology Beth Israel Deaconess Medical Center Boston MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael R.","family":"Jaff","sequence":"additional","affiliation":[{"name":"Eifers Cardiovascular Center Newton\u2010Wellesley Hospital Newton Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2839","authenticated-orcid":false,"given":"William A.","family":"Gray","sequence":"additional","affiliation":[{"name":"Main Line Health, Lankenau Heart Group Wynnewood Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Magnuson","sequence":"additional","affiliation":[{"name":"St Luke's Hospital and University of Missouri\u2010Kansas City School of Medicine Saint Luke's Mid America Heart Institute Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Li","sequence":"additional","affiliation":[{"name":"St Luke's Hospital and University of Missouri\u2010Kansas City School of Medicine Saint Luke's Mid America Heart Institute Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Feiring","sequence":"additional","affiliation":[{"name":"Division of Cardiology Columbia St. Mary's Hospital Milwaukee Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cioppi","sequence":"additional","affiliation":[{"name":"Vascular Surgery Associates, P.C. Huntsville Alabama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hibbard","sequence":"additional","affiliation":[{"name":"Bryan LGH Heart Institute Lincoln Nebraska"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce","family":"Gray","sequence":"additional","affiliation":[{"name":"Department of Surgery, Vascular Medicine Division Greenville Hospital Greenville South Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yazan","family":"Khatib","sequence":"additional","affiliation":[{"name":"First Coast Cardiovascular Institute Jacksonville Florida"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8529-8410","authenticated-orcid":false,"given":"David","family":"Jessup","sequence":"additional","affiliation":[{"name":"CarolinaEast Heart Center New Bern North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Patarca","sequence":"additional","affiliation":[{"name":"Johnson and Johnson New Brunswick New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Du","sequence":"additional","affiliation":[{"name":"Cordis Clinical Research Milpitas California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans\u2010Peter","family":"Stoll","sequence":"additional","affiliation":[{"name":"Biosensors Clinical Research Morges Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Massaro","sequence":"additional","affiliation":[{"name":"Harvard Clinical Research Institute Boston Massachusetts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Safley","sequence":"additional","affiliation":[{"name":"St Luke's Hospital and University of Missouri\u2010Kansas City School of Medicine Saint Luke's Mid America Heart Institute Kansas City Missouri"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"STROLL Study Investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1583\/JEVT-12-3898C.1"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2014.09.018"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1583\/JEVT-12-3898R.1"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.688341"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051303"},{"key":"e_1_2_8_7_1","first-page":"CD006767","article-title":"Angioplasty versus bare metal stenting for superficial femoral artery lesions","volume":"6","author":"Chowdhury MM","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.23064"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.11.026"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1583\/05-1672.1"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.25895"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016900"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.27058"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2003.08.001"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.643346"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-015-1060-0"},{"key":"e_1_2_8_17_1","unstructured":"WareJE.2002. How to Score Version 2 of the SF\u201012 Health Survey: With a Supplement Documenting Version 1: QualityMetric Incorporated."},{"key":"e_1_2_8_18_1","volume-title":"Determining Important Differences in Scores. User's Manual for the SF\u201036v2 Health Survey","author":"Ware JE","year":"2007"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200503000-00003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.109.903468"},{"key":"e_1_2_8_21_1","unstructured":"SchneiderPA.Four\u2010year results of the IN.PACT SFA Trial: drug\u2010coated balloon catheter vs. an uncoated balloon catheter in femoropopliteal lesions. 2017 September 12 2017; Presented at VIVA2017: Las Vegas NV."},{"key":"e_1_2_8_22_1","first-page":"e005891","article-title":"Treatment effect of drug\u2010coated balloons is durable to 3 years in the femoropopliteal arteries: Long\u2010term results of the IN","volume":"11","author":"Schneider PA","year":"2018","journal-title":"PACT SFA randomized trial. Circ Cardiovasc Interv"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1583\/11-3627.1"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1583\/11-3581.1"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.21104"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvs.2013.10.050"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.12.043"},{"key":"e_1_2_8_28_1","first-page":"316","article-title":"Twelve\u2010month results of percutaneous endovascular reconstruction for chronically occluded superficial femoral arteries: A quality\u2010of\u2010life assessment","volume":"18","author":"Dippel E","year":"2006","journal-title":"J Invasive Cardiol"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.27569","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.27569","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T10:11:28Z","timestamp":1694945488000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.27569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1002\/ccd.27569"],"URL":"https:\/\/doi.org\/10.1002\/ccd.27569","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]}}}